| 1 |
33673187 | The Cholesterol-Lowering Effect of Capsella Bursa-Pastoris Is Mediated via SREBP2 and HNF-1α-Regulated PCSK9 Inhibition in Obese Mice and HepG2 Cells. | 2021 Feb 12 |
1 |
| 2 |
30741744 | Comparative effects of high-dose atorvastatin versus rosuvastatin on lipid parameters, oxidized low-density lipoprotein, and proprotein convertase subtilisin kexin 9 in acute coronary syndrome. | 2019 Jun |
2 |
| 3 |
31448346 | Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins? | 2019 |
1 |
| 4 |
28616272 | The effects of additional ezetimibe treatment to baseline rosuvastatin on circulating PCSK9 among patients with stable angina. | 2017 May |
3 |
| 5 |
27878791 | New concepts in the management of dyslipidaemiaa. | 2016 |
1 |
| 6 |
22065156 | Rosuvastatin, proprotein convertase subtilisin/kexin type 9 concentrations, and LDL cholesterol response: the JUPITER trial. | 2012 Jan |
4 |
| 7 |
22331829 | Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. | 2012 Apr 1 |
1 |
| 8 |
21262787 | Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9. | 2011 Apr |
3 |